Skip to main content
S&P 5007,720.39-0.30%DOW52,342.56-0.25%NASDAQ26,184.72-1.38%BTC$77,045.00-4.95%ETH$2,215.83-5.85%GOLD$4,026.60-0.12%OIL$102.79+0.77%
Smart Investors Daily
SID Premium
OP

NASDAQ · OPRX

OptimizeRx Corporation

Healthcare · Medical - Healthcare Information Services

$9.37

Up+$0.07 (+0.75%)

Updated Oct 30, 2026, 3:48 AM

SID Score

5.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
259.66M
P/E ratio
7,647.53
Dividend yield
0.00%
52-week range
$4.54 – $9.60
Volume
100.51K
Avg. volume
304.06K

Price performance · OPRX

OPRX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

OPRX closed at $9.37 after 21 trading sessions, up 11.68% for the selected period.

Last close
$9.37
Period change
+11.68%
Period low
$8.22
Period high
$9.37
Daily close
View OHLC price history
OPRX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$9.26$9.47$9.231$9.37100.51K
Oct 28, 2026$9.10$9.46$9.10$9.3097.17K
Oct 27, 2026$9.07$9.28$8.97$9.06107.03K
Oct 26, 2026$9.15$9.25$8.93$9.07141.84K
Oct 23, 2026$9.08$9.31$8.89$9.1577.1K
Oct 22, 2026$9.24$9.33$9.01$9.08134.28K
Oct 21, 2026$8.93$9.60$8.555$9.37187.05K
Oct 20, 2026$8.71$9.08$8.57$8.93157.75K
Oct 19, 2026$8.40$8.90$8.40$8.74130.59K
Oct 16, 2026$8.89$8.99$8.495$8.50101.53K
Oct 15, 2026$8.20$8.91$8.11$8.85151.52K
Oct 14, 2026$8.52$8.52$8.22$8.2981.52K
Oct 13, 2026$8.25$8.59$8.25$8.425154.76K
Oct 12, 2026$8.30$8.35$8.14$8.22142.9K
Oct 9, 2026$8.43$8.58$8.28$8.28123.2K
Oct 8, 2026$8.52$8.52$8.20$8.38211.57K
Oct 7, 2026$8.74$8.9901$8.38$8.55162.12K
Oct 6, 2026$8.82$9.18$8.79$8.81171.94K
Oct 5, 2026$8.60$8.785$8.45$8.72166.71K
Oct 2, 2026$8.55$8.76$8.31$8.57224.86K
Oct 1, 2026$8.42$8.86$8.295$8.39196.47K

Latest OPRX news

The latest Smart Investors Daily articles mentioning OPRX.

Stock researchCompany · Overview

OPRX research

Overview

Company profile and research snapshot.

Company profile

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$23.00
Implied upside
—
Analysts
—
OPRX recent ratings
DateFirmRatingTarget
Sep 29, 2026B. Riley SecuritiesBuy—
Aug 14, 2026CitizensMarket Outperform—
May 13, 2026Lake StreetBuy—
May 13, 2026Stephens & Co.Equal-Weight—
May 13, 2026B. Riley SecuritiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 28, 2026

OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET

WALTHAM, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at critical decision points, will hold a conference call on Wednesday, November 11, 2026, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2026. The financial results will be issued in a press release pri

Yahoo · Oct 27, 2026

OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel

Latest DSP integration expands buyer access to OptimizeRx point of care inventory through existing programmatic workflowsWALTHAM, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a healthcare technology company helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at critical decision points, today announced a new partnership with PulsePoint, an award-winning programmatic platform advancing omnichannel healthcare ma

Yahoo · Oct 22, 2026

Trade Desk Integration and Programmatic Capabilities Drive OptimizeRx’s (OPRX) Q4 Catalyst

White Brook Capital’s Q3 2026 investor letter expresses cautious optimism. Its Ethical All-Cap Strategy has outperformed, while the Small Cap Strategy has lagged because of execution delays, higher interest rates, and market pressure. You can download a copy of the letter here. The economy remains resilient, supported by AI infrastructure investment, consumer spending, healthcare research, […]

Yahoo · Oct 2, 2026

What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders

In September 2026, OptimizeRx Corp. announced it had integrated its authenticated point of care inventory with The Trade Desk’s OpenPath, giving advertisers direct programmatic access via The Trade Desk’s demand side platform to a proprietary healthcare network spanning more than 400 EHR and e-prescribe systems and 800,000 verified healthcare professionals. This move deepens The Trade Desk’s healthcare-focused inventory and could make its platform more attractive to life sciences advertisers...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By